Pharmaceutical products
Original notice title
France-Fleury-les-Aubrais: Pharmaceutical products
Opportunity Score
Why this score?
Opportunity
35 / 100
Complexity
40 / 100
Risk factors
Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...
Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- DAPSA
- Country
- France
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Mar 21, 2030
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational use by the French Ministry of Defence.
- The contract covers three distinct lots: vaccines, medicines, and parapharmacy products.
Show full summary
This is a restricted procedure notice for the supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational purposes, issued by the French Ministry of Defence (ema/dcssa/daps-ssa). The notice was published on 2022-02-14, but the submission deadline is unusually far in the future (2030-03-21), likely indicating a dynamic purchasing system (DPS) despite structured data flags. Three lots are identified from the XML notice. No estimated value is provided. No procurement documents were analyzed beyond the notice itself.
Risks
Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...
Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...
Restricted procedure — pre-qualification required
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Procedure is restricted (structured data) but XML indicates a dynamic purchasing system (inconsistency noted).
Administrative
- Submission is allowed for all lots (based on XML notice: 'TY TYPE BID: Submission for all lots').
- Language: French (FRA) is required for submission.
Buyer
Name
Location
chanteau, FRA
Website
Buyer profile
Identifier
15100002301258
Activity
Defence
Lots (3)
1
vaccins à visée opérationnelle
Supply of vaccines for operational purposes.
Category
Deadline
2
médicaments à visée opérationnelle
Supply of medicines for operational purposes.
Category
Deadline
3
produits de parapharmacie à visée opérationnelle
Supply of parapharmacy products for operational purposes.
Category
Deadline
Procurement Details
- Publication date
- 14 Feb 2022
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 81444-2022
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
35 / 100
Complexity
40 / 100
Risk factors
Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...
Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications